712 related articles for article (PubMed ID: 24630704)
1. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention.
Ndrepepa G; Braun S; Cassese S; Fusaro M; King L; Kastrati A; Schmidt R
Cardiovasc Revasc Med; 2013; 14(5):264-9. PubMed ID: 23969223
[TBL] [Abstract][Full Text] [Related]
3. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
[TBL] [Abstract][Full Text] [Related]
4. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
[TBL] [Abstract][Full Text] [Related]
5. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.
Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S
Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547
[TBL] [Abstract][Full Text] [Related]
6. Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol.
Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Shiba M; Wada M; Tsuji T; Komatsu H; Iijima R; Nakajima R; Yamamoto M; Yamamoto M; Yoshitama T; Takagi T; Hara H; Sugi K
J Cardiol; 2007 Mar; 49(3):115-23. PubMed ID: 17444137
[TBL] [Abstract][Full Text] [Related]
7. Correlates of poor outcome among patients with bleeding after coronary interventions.
Ndrepepa G; Guerra E; Schulz S; Hoppmann P; Laugwitz KL; Kastrati A
Coron Artery Dis; 2014 Sep; 25(6):456-62. PubMed ID: 24801558
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
Puri R; Nissen SE; Libby P; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
Circulation; 2013 Nov; 128(22):2395-403. PubMed ID: 24043299
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.
Razzouk L; Muntner P; Bansilal S; Kini AS; Aneja A; Mozes J; Ivan O; Jakkula M; Sharma S; Farkouh ME
Am Heart J; 2009 Aug; 158(2):277-83. PubMed ID: 19619706
[TBL] [Abstract][Full Text] [Related]
10. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
[TBL] [Abstract][Full Text] [Related]
11. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.
Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G
Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.
Herrmann J; Lennon RJ; Barsness GW; Sandhu GS; Gulati R; Best PJ; Sorajja P; Bresnahan JF; Mathew V; Bell MR; Prasad A
Circ Cardiovasc Interv; 2012 Dec; 5(6):783-90. PubMed ID: 23212397
[TBL] [Abstract][Full Text] [Related]
13. [Early initiation of statin therapy in patients with acute myocardial infarction after successful percutaneous coronary intervention].
Katayama N; Nakao K; Horiuchi K; Ogawa H; Honda T
J Cardiol; 2004 Oct; 44(4):131-40. PubMed ID: 15532243
[TBL] [Abstract][Full Text] [Related]
14. Association of uric acid with mortality in patients with stable coronary artery disease.
Ndrepepa G; Braun S; King L; Hadamitzky M; Haase HU; Birkmeier KA; Schömig A; Kastrati A
Metabolism; 2012 Dec; 61(12):1780-6. PubMed ID: 22749121
[TBL] [Abstract][Full Text] [Related]
15. Comparative prognostic value of C-reactive protein & fibrinogen in patients with coronary artery disease.
Ndrepepa G; Braun S; Tada T; King L; Cassese S; Fusaro M; Keta D; Kastrati A; Schmidt R
Indian J Med Res; 2014 Sep; 140(3):392-400. PubMed ID: 25366207
[TBL] [Abstract][Full Text] [Related]
16. Low high-density lipoprotein cholesterol is a residual risk factor associated with long-term clinical outcomes in diabetic patients with stable coronary artery disease who achieve optimal control of low-density lipoprotein cholesterol.
Ogita M; Miyauchi K; Miyazaki T; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Yokoyama T; Okazaki S; Kurata T; Daida H
Heart Vessels; 2014 Jan; 29(1):35-41. PubMed ID: 23516028
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein levels and outcomes after statin therapy.
Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E;
N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109
[TBL] [Abstract][Full Text] [Related]
18. Progression of asymptomatic carotid stenosis despite optimal medical therapy.
Conrad MF; Boulom V; Mukhopadhyay S; Garg A; Patel VI; Cambria RP
J Vasc Surg; 2013 Jul; 58(1):128-35.e1. PubMed ID: 23806255
[TBL] [Abstract][Full Text] [Related]
19. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
[TBL] [Abstract][Full Text] [Related]
20. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
McMurray JJ; Kjekshus J; Gullestad L; Dunselman P; Hjalmarson A; Wedel H; Lindberg M; Waagstein F; Grande P; Hradec J; Kamenský G; Korewicki J; Kuusi T; Mach F; Ranjith N; Wikstrand J;
Circulation; 2009 Dec; 120(22):2188-96. PubMed ID: 19917888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
